EP2393808
CRYSTALLINE FORM OF R)-3-(4-(2-(2-METHYLTETRAZOL-5-YL)PYRIDIN-5-YL)-3-FLUOROPHENYL)-5-HYDROXYMETHYL OXAZOLIDIN-2-ONE DIHYDROGEN PHOSPHATE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.2.2010EP published:
8.5.2019EP application number:
10703403.5
EPO information:
European Patent Register
Max expiry date:
2.2.2030
Title:
CRYSTALLINE FORM OF R)-3-(4-(2-(2-METHYLTETRAZOL-5-YL)PYRIDIN-5-YL)-3-FLUOROPHENYL)-5-HYDROXYMETHYL OXAZOLIDIN-2-ONE DIHYDROGEN PHOSPHATE
Timeline
Today
3.2.2010EP application
8.5.2019EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, 07065, Rahway, NJ, US
Inventor
Name:
PHILLIPSON, DouglasAddress:
Del Mar, CA, US
Name:
REICHENBACHER, KatharinaAddress:
Riehen, CH
Name:
DUGUID, Robert J.Address:
Glenmont, NY, US
Name:
WARE, Jacqueline, A.Address:
Virginia BeachVA, US
Priority
Number:
149402 PDate:
3.2.2009Country:
US
Classification
Categories:
C07D 413/14, A61K 31/675, A61P 31/04